Cellectar Biosciences (CLRB) Total Debt (2010 - 2020)
Cellectar Biosciences (CLRB) posted Total Debt of $184000.0 for Q3 2020, little changed sequentially from $184000.0 in Q2 2020.
Cellectar Biosciences (CLRB) Total Debt (2010 - 2020) Analysis & Trends
Cellectar Biosciences has reported Total Debt for 8 years, with the latest figure at $184000.0 in Q3 2020.
- Quarterly Total Debt changed N/A year-over-year to $184000.0 in Q3 2020, while the trailing twelve-month figure through Sep 2020 was $184000.0 (changed N/A YoY) and the FY2015 annual result came in at $86632.0, down 73.75% from the prior year.
- Total Debt held at $184000.0 in Q3 2020 per CLRB's latest filing, from $184000.0 in the prior quarter.
- Over five years, Total Debt peaked at $184000.0 in Q2 2020 and troughed at $24885.0 in Q1 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.95 Bn | 132.10 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.71 Bn | 78.72 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 65.71 Bn | 60.52 Bn | 1.37 Bn | - |
| 4 | Moderna | 60.45 Bn | 55.31 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 42.24 Bn | 37.14 Bn | 1.53 Bn | 1.07 Bn |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.64 Bn | 10.25 Bn | 668.28 Mn | 770.36 Mn |
| 8 | Insmed | 27.61 Bn | 26.45 Bn | 358.27 Mn | 546.77 Mn |
| 9 | Royalty Pharma | 27.26 Bn | 26.42 Bn | - | 9.34 Bn |
| 10 | Cellectar Biosciences | 6.78 Mn | 6.78 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 184,000.00 |
| Jun 30, 2020 | 184,000.00 |
| Mar 31, 2016 | 24,885.00 |
| Dec 31, 2015 | 86,632.00 |
| Sep 30, 2015 | 147,919.00 |
| Jun 30, 2015 | 208,925.00 |
| Mar 31, 2015 | 269,630.00 |
| Dec 31, 2014 | 330,077.00 |
| Sep 30, 2014 | 346,675.00 |
| Jun 30, 2014 | 408,670.00 |
| Mar 31, 2014 | 450,000.00 |
| Dec 31, 2013 | 450,000.00 |
| Sep 30, 2013 | 450,000.00 |
| Jun 30, 2013 | 450,000.00 |
| Mar 31, 2013 | 450,000.00 |
| Dec 31, 2012 | 450,000.00 |
| Sep 30, 2012 | 450,000.00 |
| Jun 30, 2012 | 450,000.00 |
| Mar 31, 2012 | 450,000.00 |
| Dec 31, 2011 | 450,000.00 |